Converting glial cells to neurons, more effective CAR-Ts, and groundbreaking IDAs… What’s new in the advanced medicine field?
James Strachan |
- The US Center for International Blood and Marrow Transplant Research (CIBMRT) is collaborating with Novartis to track the long-term outcomes of patients treated with CAR-T cell therapies. The alliance will collect and examine real-world data about the use of Kymriah, and is encouraging all US centers to offer patient participation in the registry. “For decades, we collected research data about hematopoietic cell transplantation (HCT),” said Marcelo Pasquini, Senior Scientific Director at CIBMTR in a press release. “Previously, HCT was the only successful cellular therapy for cancer. We look forward to expanding into the field of targeted cellular therapies to help people with cancer.”
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Login if you already created an account
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine